查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
間質幹細胞的全球市場(2022年～2032年)
市場調查報告書
商品編碼
1127670

間質幹細胞的全球市場(2022年～2032年)

Mesenchymal Stem Cells Market Report 2022-2032
出版日期: | 出版商: Visiongain Reports Ltd. | 英文 282 Pages | 商品交期: 最快1-2個工作天內

價格

全球間質幹細胞的市場規模，2021年是24億4,000萬美金，在預測期間(2022年～2032年)預計以13.82％的年複合成長率成長。各種治療領域的用途擴大和臨床試驗數增加，成為市場成長的推動要素。但，間質幹細胞的移植技術，及特定的細胞擴大中有問題。

本報告提供全球間質幹細胞市場相關調查，市場規模和預測，市場動態，各市場區隔、地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
  • COVID-19影響分析
  • 波特的五力分析
  • 大環境分析

第4章 間質幹細胞市場分析:各類型

  • 主要調查結果
  • 類型市場區隔的成長預測
  • 各類型:間質幹細胞的市場規模估計、預測
  • 產品
  • 細胞，細胞株
  • 套件，培養基，試劑
  • 其他
  • 服務

第5章 間質幹細胞市場分析:各原料

  • 主要調查結果
  • 原料市場區隔的成長預測
  • 各原料:間質幹細胞的市場規模估計、預測
  • 骨髓
  • 脂肪組織
  • 臍帶血
  • 胎兒肝
  • 肺
  • 末梢血
  • 輸卵管
  • 其他

第6章 間質幹細胞市場分析:各適應症

  • 主要調查結果
  • 適應症市場區隔的成長預測
  • 各適應症:間質幹細胞的市場規模估計、預測
  • 骨、軟骨的修復
  • 心血管疾病
  • 癌症
  • GvHD
  • 發炎性及免疫疾病
  • 肝疾病
  • 其他

第7章 間質幹細胞市場分析:各用途

  • 主要調查結果
  • 用途市場區隔的成長預測
  • 各用途:間質幹細胞的市場規模估計、預測
  • 疾病建模
  • 藥物研發與開發
  • 幹細胞銀行
  • 人組織工程
  • 毒物學研究
  • 其他

第8章 間質幹細胞市場分析:各地區

  • 主要調查結果
  • 地區的市場規模估計、預測

第9章 北美的間質幹細胞市場分析

  • 主要調查結果
  • 市場魅力指數
  • 市場規模:各國(金額，2022年，2027年，2032年)
  • 市場規模估計、預測:各國(金額，2022年～2032年)
  • 市場規模估計、預測:各類型(金額，2022年～2032年)
    • 市場規模:各產品(金額，2022年～2032年)
  • 市場規模估計、預測:各原料(金額，2022年～2032年)
  • 市場規模估計、預測:各適應症(金額，2022年～2032年)
  • 市場規模估計、預測:各用途(金額，2022年～2032年)
  • 美國
  • 加拿大

第10章 歐洲間質幹細胞市場分析

  • 主要調查結果
  • 市場魅力指數
  • 市場規模:各國(金額，2022年，2027年，2032年)
  • 市場規模估計、預測:各國(金額，2022年～2032年)
  • 市場規模估計、預測:各類型(金額，2022年～2032年)
    • 市場規模:各產品(金額，2022年～2032年)
  • 市場規模估計、預測:各原料(金額，2022年～2032年)
  • 市場規模估計、預測:各適應症(金額，2022年～2032年)
  • 市場規模估計、預測:各用途(金額，2022年～2032年)
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他歐洲

第11章 亞太地區間質幹細胞市場分析

  • 主要調查結果
  • 市場魅力指數
  • 市場規模:各國(金額，2022年，2027年，2032年)
  • 市場規模估計、預測:各國(金額，2022年～2032年)
  • 市場規模估計、預測:各類型(金額，2022年～2032年)
    • 市場規模:各產品(金額，2022年～2032年)
  • 市場規模估計、預測:各原料(金額，2022年～2032年)
  • 市場規模估計、預測:各適應症(金額，2022年～2032年)
  • 市場規模估計、預測:各用途(金額，2022年～2032年)
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 其他亞太地區

第12章 南美間質幹細胞市場分析

  • 主要調查結果
  • 市場魅力指數
  • 市場規模:各國(金額，2022年，2027年，2032年)
  • 市場規模估計、預測:各國(金額，2022年～2032年)
  • 市場規模估計、預測:各類型(金額，2022年～2032年)
    • 市場規模:各產品(金額，2022年～2032年)
  • 市場規模估計、預測:各原料(金額，2022年～2032年)
  • 市場規模估計、預測:各適應症(金額，2022年～2032年)
  • 市場規模估計、預測:各用途(金額，2022年～2032年)
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他南美國家

第13章 中東、非洲間質幹細胞市場分析

  • 主要調查結果
  • 市場魅力指數
  • 市場規模:各國(金額，2022年，2027年，2032年)
  • 市場規模估計、預測:各國(金額，2022年～2032年)
  • 市場規模估計、預測:各類型(金額，2022年～2032年)
    • 市場規模:各產品(金額，2022年～2032年)
  • 市場規模估計、預測:各原料(金額，2022年～2032年)
  • 市場規模估計、預測:各適應症(金額，2022年～2032年)
  • 市場規模估計、預測:各用途(金額，2022年～2032年)
  • 沙烏地阿拉伯
  • 南非
  • 土耳其
  • 其他中東

第14章 企業簡介

  • 企業佔有率分析
  • Key Business Strategy Analysis
  • Thermo Fisher Scientific Inc.
  • Merck KGaA(Millipore Sigma)
  • STEMCELL Technologies Inc.
  • Cytori Therapeutics Inc.(Plus Therapeutics, Inc)
  • Cyagen Biosciences
  • PromoCell GmbH
  • Celprogen Inc.
  • Stemedica Cell Technologies, Inc.
  • Cell Applications, Inc
  • Lonza
  • Celltex Therapeutics Corporation

第15章 結論與建議

  • 結論
  • 市場相關人員的建議
Product Code: PHA1193

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

“The Mesenchymal Stem Cells Market Report 2022-2032”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors Such As Application In Various Therapy Areas and Rising Number of Clinical Trials are Driving the Market Growth

Some of the major factors propelling the mesenchymal stem cells market include wide application of Mesenchymal stem cells in a range of fields, including haematological disease, graft-versus-host disease, organ transplantation, diabetes, inflammatory diseases, and diseases in the liver, kidney, and lung, as well as cardiovascular, bone and cartilage, neurological, and autoimmune diseases. Increasing number of clinical trials in mesenchymal stem cell-based therapies is one of the major factors driving the market. The number of new reported phase I and II MSC clinical trials have expanded consistently over the past fifteen years and Increasing investment and funding for mesenchymal stem cell research and rising incidence of orthopaedic disorder and increase in cancer incidences are anticipated to support the global market growth

Challenges in Technology Transfer and Limited Expansion of Mesenchymal Stem Cells

Transferring of MSCs from bench to bedside is theoretically highly attainable, however, many failures have been reported in clinical trials, resulting in FDA rejection. Heterogeneity of MSCs from donors arise due to factors such as age, gender, genetic makeup and medical health condition. It has been also observed that there is difference in the differentiation capacities and the degree of stemness between mesenchymal stem cells isolated from different sources such as adipose tissue, bone marrow, muscles and umbilical cord. Inconsistency in further expansion capacities such as culture conditions, flasks / bioreactors passage number, oxygen levels, and cell surface modifications. Moreover MSCs also have the ability to differentiate into various cell types such as hepatocyte, neural cells and pancreatic islet cells. Hence, there are fair chances that in vitro induction of MSCs would not yield pure competent cells needed for the treatment of the disease.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the mesenchymal stem cells market evolving?
  • What is driving and restraining the mesenchymal stem cells market?
  • How will each mesenchymal stem cells submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each mesenchymal stem cells submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading mesenchymal stem cells markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the mesenchymal stem cells projects for these leading companies?
  • How will the industry evolve during the period between 2022 and 2032? What are the implications of mesenchymal stem cells projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the mesenchymal stem cells market?
  • Where is the mesenchymal stem cells market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the mesenchymal stem cells market today, and over the next 10 years:

  • Our 282-page report provides 117 tables and 184 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Mesenchymal Stem Cells market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising investment in mesenchymal stem cells and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Type

  • Products
    • Cell & Cell Lines
    • Kits Media & Reagents
    • Others
  • Service

Source

  • Bone marrow
  • Adipose Tissue
  • Cord Blood
  • Fetal Liver
  • Lung
  • Peripheral Blood
  • Fallopian Tube
  • Other Sources

Indication

  • Bone & cartilage Repair
  • Cardiovascular Disease
  • Cancer
  • GvHD
  • Inflammatory & Immunological Diseases
  • Liver Diseases
  • Other Indication

Application

  • Disease Modelling
  • Drug Discovery & Development
  • Stemcell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 17 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • Saudi Arabia
  • South Africa
  • Turkey
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Mesenchymal Stem Cells Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Cell Application Inc.
  • Celltex Therapeutics Corporation.
  • Celprogen Inc.
  • Cyagen Biosciences
  • Cytori Therapeutics Inc. (Plus Therapeutics Inc.)
  • Lonza
  • Merck KGaA (Millipore Sigma)
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Stemedica Cell Technologies Inc.
  • Thermo Fischer Scientific Inc.

Overall global revenue for Mesenchymal Stem Cells Market, 2022 to 2032 in terms of value the market will surpass US$2.75 billion in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Mesenchymal Stem Cells Market, 2022 to 2032 report help you?

In summary, our 280+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Mesenchymal Stem Cells Market, 2022 to 2032 Market, with forecasts for Type, Source, Indication and Application, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2032 for five regional and 17 key national markets - See forecasts for the Mesenchymal Stem Cells Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LATAM and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 11 of the major companies involved in the Mesenchymal Stem Cells Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Mesenchymal Stem Cells Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Mesenchymal Stem Cells Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
    • 3.2.2 Market Restraining Factors
    • 3.2.3 Market Opportunities
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PESTLE Analysis

4 Mesenchymal Stem Cells Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment Growth Prospects
  • 4.3 Mesenchymal Stem Cells Market Size Estimation and Forecast by Type
  • 4.4 Products
    • 4.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 4.4.2 Market Share by Region, 2022 & 2032 (%)
  • 4.5 Cell & Cell Lines
    • 4.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 4.5.2 Market Share by Region, 2022-2032 (%)
  • 4.6 Kits, Media & Reagents
    • 4.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 4.6.2 Market Share by Region, 2022-2032 (%)
  • 4.7 Others
    • 4.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 4.7.2 Market Share by Region, 2022-2032 (%)
  • 4.8 Services
    • 4.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 4.8.2 Market Share by Region, 2022-2032 (%)

5 Mesenchymal Stem Cells Market Analysis by Source

  • 5.1 Key Findings
  • 5.2 Source Segment Growth Prospects
  • 5.3 Mesenchymal Stem Cells Market Size Estimation and Forecast by Source
  • 5.4 Bone Marrow
    • 5.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.4.2 Market Share by Region, 2022 & 2032 (%)
  • 5.5 Adipose Tissues
    • 5.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.5.2 Market Share by Region, 2022 & 2032 (%)
  • 5.6 Cord Blood
    • 5.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.6.2 Market Share by Region, 2022 & 2032 (%)
  • 5.7 Fetal Liver
    • 5.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.7.2 Market Share by Region, 2022 & 2032 (%)
  • 5.8 Lung
    • 5.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.8.2 Market Share by Region, 2022 & 2032 (%)
  • 5.9 Peripheral Blood
    • 5.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.9.2 Market Share by Region, 2022 & 2032 (%)
  • 5.10 Fallopian Tube
    • 5.10.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.10.2 Market Share by Region, 2022 & 2032 (%)
  • 5.11 Others
    • 5.11.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 5.11.2 Market Share by Region, 2022-2032 (%)

6 Mesenchymal Stem Cells Market Analysis by Indication

  • 6.1 Key Findings
  • 6.2 Indication Segment Growth Prospects
  • 6.3 Mesenchymal Stem Cells Market Size Estimation and Forecast by Indication
  • 6.4 Bone And Cartilage Repair
    • 6.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.4.2 Market Share by Region, 2022&2032 (%)
  • 6.5 Cardiovascular Diseases
    • 6.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.5.2 Market Share by Region, 2022-2032 (%)
  • 6.6 Cancer
    • 6.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.6.2 Market Share by Region, 2022 & 2032 (%)
  • 6.7 GvHD
    • 6.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.7.2 Market Share by Region, 2022 & 2032 (%)
  • 6.8 Inflammatory And Immunological Diseases
    • 6.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.8.2 Market Share by Region, 2022 & 2032 (%)
  • 6.9 Liver Diseases
    • 6.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.9.2 Market Share by Region, 2022 & 2032 (%)
  • 6.10 Others
    • 6.10.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 6.10.2 Market Share by Region, 2022 & 2032 (%)

7 Mesenchymal Stem Cells Market Analysis by Application

  • 7.1 Key Findings
  • 7.2 Application Segment Growth Prospects
  • 7.3 Mesenchymal Stem Cells Market Size Estimation and Forecast by Application
  • 7.4 Disease Modelling
    • 7.4.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.4.2 Market Share by Region, 2022 & 2032 (%)
  • 7.5 Drug Discovery & Development
    • 7.5.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.5.2 Market Share by Region, 2022-2032 (%)
  • 7.6 Stem Cell Banking
    • 7.6.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.6.2 Market Share by Region, 2022 & 2032 (%)
  • 7.7 Tissue Engineering
    • 7.7.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.7.2 Market Share by Region, 2022 & 2032 (%)
  • 7.8 Toxicology Studies
    • 7.8.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.8.2 Market Share by Region, 2022 & 2032 (%)
  • 7.9 Others
    • 7.9.1 Market Forecast by Region, 2022-2032 (US$ Mn)
    • 7.9.2 Market Share by Region, 2022-2032 (%)

8 Mesenchymal Stem Cells Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Mesenchymal Stem Cells Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Mesenchymal Stem Cells Market Attractiveness Index
  • 9.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
  • 9.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
  • 9.5 Market Size Estimation and Forecast by Type, 2022-2032 (US$ Mn)
    • 9.5.1 Market Size by Products, 2022-2032 (US$ Mn)
  • 9.6 Market Size Estimation and Forecast by Source, 2022-2032 (US$ Mn)
  • 9.7 Market Size Estimation and Forecast by Indication, 2022-2032 (US$ Mn)
  • 9.8 Market Size Estimation and Forecast by Application, 2022-2032 (US$ Mn)
  • 9.9 U.S.
  • 9.10 Canada

10 Europe Mesenchymal Stem Cells Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Mesenchymal Stem Cells Market Attractiveness Index
  • 10.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
  • 10.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
  • 10.5 Market Size Estimation and Forecast by Type, 2022-2032 (US$ Mn)
    • 10.5.1 Market Size by Products, 2022-2032 (US$ Mn)
  • 10.6 Market Size Estimation and Forecast by Source, 2022-2032 (US$ Mn)
  • 10.7 Market Size Estimation and Forecast by Indication, 2022-2032 (US$ Mn)
  • 10.8 Market Size Estimation and Forecast by Application, 2022-2032 (US$ Mn)
  • 10.9 Germany
  • 10.10 France
  • 10.11 U.K.
  • 10.12 Italy
  • 10.13 Spain
  • 10.14 Rest of Europe

11 Asia Pacific Mesenchymal Stem Cells Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Mesenchymal Stem Cells Market Attractiveness Index
  • 11.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
  • 11.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
  • 11.5 Market Size Estimation and Forecast by Type, 2022-2032 (US$ Mn)
    • 11.5.1 Market Size by Products, 2022-2032 (US$ Mn)
  • 11.6 Market Size Estimation and Forecast by Source, 2022-2032 (US$ Mn)
  • 11.7 Market Size Estimation and Forecast by Indication, 2022-2032 (US$ Mn)
  • 11.8 Market Size Estimation and Forecast by Application, 2022-2032 (US$ Mn)
  • 11.9 China
  • 11.10 Japan
  • 11.11 India
  • 11.12 Australia
  • 11.13 Rest of Asia Pacific

12 Latin America Mesenchymal Stem Cells Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Mesenchymal Stem Cells Market Attractiveness Index
  • 12.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
  • 12.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
  • 12.5 Market Size Estimation and Forecast by Type, 2022-2032 (US$ Mn)
    • 12.5.1 Market Size by Products, 2022-2032 (US$ Mn)
  • 12.6 Market Size Estimation and Forecast by Source, 2022-2032 (US$ Mn)
  • 12.7 Market Size Estimation and Forecast by Indication, 2022-2032 (US$ Mn)
  • 12.8 Market Size Estimation and Forecast by Application, 2022-2032 (US$ Mn)
  • 12.9 Brazil
  • 12.10 Mexico
  • 12.11 Argentina
  • 12.12 Rest of Latin America

13 Middle East & Africa Mesenchymal Stem Cells Market Analysis

  • 13.1 Key Findings
  • 13.2 Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Index
  • 13.3 Market Size by Country, 2022, 2027 & 2032 (US$ Mn)
  • 13.4 Market Size Estimation and Forecast by Country, 2022-2032 (US$ Mn)
  • 13.5 Market Size Estimation and Forecast by Type, 2022-2032 (US$ Mn)
    • 13.5.1 Market Size by Products, 2022-2032 (US$ Mn)
  • 13.6 Market Size Estimation and Forecast by Source, 2022-2032 (US$ Mn)
  • 13.7 Market Size Estimation and Forecast by Indication, 2022-2032 (US$ Mn)
  • 13.8 Market Size Estimation and Forecast by Application, 2022-2032 (US$ Mn)
  • 13.9 Saudi Arabia
  • 13.10 South Africa
  • 13.11 Turkey
  • 13.12 Rest of Middle East & Africa

14 Company Profiles

  • 14.1 Company Share Analysis
  • 14.2 Key Business Strategy Analysis
  • 14.3 Thermo Fisher Scientific Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Merck KGaA (Millipore Sigma)
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 STEMCELL Technologies Inc.
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Product Benchmarking
    • 14.5.4 Strategic Outlook
  • 14.6 Cytori Therapeutics Inc. (Plus Therapeutics, Inc)
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Product Benchmarking
  • 14.7 Cyagen Biosciences
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Product Benchmarking
    • 14.7.4 Strategic Outlook
  • 14.8 PromoCell GmbH
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Product Benchmarking
  • 14.9 Celprogen Inc.
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Product Benchmarking
  • 14.10 Stemedica Cell Technologies, Inc.
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Product Benchmarking
    • 14.10.4 Strategic Outlook
  • 14.11 Cell Applications, Inc
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Product Benchmarking
  • 14.12 Lonza
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 Celltex Therapeutics Corporation
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Product Benchmarking
    • 14.13.4 Strategic Outlook

15 Conclusion and Recommendation

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Mesenchymal Stem Cells Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
  • Table 2 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR(%)): "V" Shaped Recovery Scenario
  • Table 3 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR(%)): "V" Shaped Recovery Scenario
  • Table 4 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 5 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 6 Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 7 Products Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 8 Cell & Cell Lines Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 9 Kits, Media & Reagent Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 10 Others Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 11 Services Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 12 Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 13 Bone Marrow Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 14 Adipose Tissues Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 15 Cord Blood Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 16 Fetal Liver Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 17 Lung Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 18 Peripheral Blood Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 19 Fallopian Tube Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 20 Others Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 21 Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 22 Bone And Cartilage Repair Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 23 Cardiovascular Diseases Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 24 Cancer Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 25 GvHD Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 26 Inflammatory And Immunological Diseases Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 27 Liver Diseases Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 28 Others Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 29 Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 30 Disease Modelling Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 31 Drug Development & Discovery Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 32 Stem Cell Banking Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 33 Tissue Engineering Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 34 Toxicology Studies Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 35 Others Market Forecast by Region, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 36 Mesenchymal Stem Cells Market by Region, 2022-2032 (US$ million, AGR (%), CAGR (%))
  • Table 37 North America Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 38 North America Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 39 North America Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 40 North America Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 41 North America Mesenchymal Stem Cell Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 42 North America Mesenchymal Stem Cell Market Forecast by Application, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 43 U.S. Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 44 Canada Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 45 Europe Mesenchymal Stem Cells Market by Country, 2022-2032 (US$ million, AGR (%), CAGR (%))
  • Table 46 Europe Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 47 Europe Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 48 Europe Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 49 Europe Mesenchymal Stem Cell Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 50 Europe Mesenchymal Stem Cell Market Forecast by Application, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 51 Germany Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 52 France Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 53 U.K. Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 54 Italy Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 55 Spain Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 56 Rest of Europe Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 57 Asia Pacific Mesenchymal Stem Cells Market by Country, 2022-2032 (US$ million, AGR (%), CAGR (%))
  • Table 58 Asia Pacific Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 59 Asia Pacific Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 60 Asia Pacific Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 61 Asia Pacific Mesenchymal Stem Cell Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 62 Asia Pacific Mesenchymal Stem Cell Market Forecast by Application, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 63 China Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 64 Japan Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 65 India Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 66 Australia Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 67 Rest of Asia Pacific Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 68 Latin America Mesenchymal Stem Cells Market by Country, 2022-2032 (US$ million, AGR (%), CAGR (%))
  • Table 69 Latin America Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 70 Latin America Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 71 Latin America Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 72 Latin America Mesenchymal Stem Cell Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 73 Latin America Mesenchymal Stem Cell Market Forecast by Application, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 74 Brazil Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 75 Mexico Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 76 Argentina Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 77 Rest of Latin America Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 78 Middle East & Africa Mesenchymal Stem Cells Market by Country, 2022-2032 (US$ million, AGR (%), CAGR (%))
  • Table 79 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 80 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 81 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 82 Middle East & Africa Mesenchymal Stem Cell Market Forecast by Indication, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 83 Middle East & Africa Mesenchymal Stem Cell Market Forecast by Application, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 84 Saudi Arabia Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 85 South Africa Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 86 Turkey Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 87 Rest of Middle East & Africa Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %, CAGR %)
  • Table 88 Key Business Strategies Adopted by Key Players in Mesenchymal Stem Cells Market
  • Table 89 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 90 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 91 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 92 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Merck KGaA: Product Benchmarking
  • Table 94 Merck KGaA: Strategic Outlook
  • Table 95 STEMCELL Technologies Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 STEMCELL Technologies: Product Benchmarking
  • Table 97 STEMCELL Technologies: Strategic Outlook
  • Table 98 Cytori Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Cytori Therapeutics Inc: Product Benchmarking
  • Table 100 Cyagen Biosciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Cyagen Biosciences: Product Benchmarking
  • Table 102 Cyagen Biosciences: Strategic Outlook
  • Table 103 PromoCell GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 PromoCell GmbH: Product Benchmarking
  • Table 105 Celprogen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Celprogen Inc: Product Benchmarking
  • Table 107 Stemedica Cell Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Stemedica Cell Technologies, Inc: Product Benchmarking
  • Table 109 Stemedica Cell Technologies, Inc: Strategic Outlook
  • Table 110 Cell Applications, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Cell Applications, Inc: Product Benchmarking
  • Table 112 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Lonza: Product Benchmarking
  • Table 114 Lonza: Strategic Outlook
  • Table 115 Celltex Therapeutics Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Celltex Therapeutics Corporation: Product Benchmarking
  • Table 117 Celltex Therapeutics Corporation: Strategic Outlook

List of Figures

  • Figure 1 Mesenchymal Stem Cells Market Segmentation
  • Figure 2 Mesenchymal Stem Cells Market Forecast by Region: Market Attractiveness Index
  • Figure 3 Mesenchymal Stem Cells Market by Type: Market Attractiveness Index
  • Figure 4 Mesenchymal Stem Cells Market by Source: Market Attractiveness Index
  • Figure 5 Mesenchymal Stem Cells Market by Indication: Market Attractiveness Index
  • Figure 6 Mesenchymal Stem Cells Market by Application: Market Attractiveness Index
  • Figure 7 Mesenchymal Stem Cells Market: Market Dynamics
  • Figure 8 Mesenchymal Stem Cells Market, 2022-2032 Covid-19 Impact Analysis
  • Figure 9 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 10 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 11 Mesenchymal Stem Cells Market by Region, 2022-2032 (US$ million, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 12 Mesenchymal Stem Cells Market, 2022-2032 (US$ million, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 13 Mesenchymal Stem Cells Market: Porter's Five Forces Analysis
  • Figure 14 Mesenchymal Stem Cells Market: PESTLE Analysis
  • Figure 15 Mesenchymal Stem Cells Market by Type Growth Prospects
  • Figure 16 Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million, AGR %)
  • Figure 17 Mesenchymal Stem Cells Market Share Forecast by Type, 2022, 2027, 2032 (%)
  • Figure 18 Products Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 19 Products Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 20 Cell & Cell Lines Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 21 Cell & Cell Lines Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 22 Kits, Media & Reagent Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 23 Kits, Media & Reagent Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 24 Others Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 25 Others Market Share Forecast by Region, 2022-2032 (%)
  • Figure 26 Services Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 27 Services Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 28 Mesenchymal Stem Cells Market by Source Growth Prospects
  • Figure 29 Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million, AGR %)
  • Figure 30 Mesenchymal Stem Cells Market Share Forecast by Source, 2022, 2027, 2032 (%)
  • Figure 31 Bone Marrow Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 32 Bone Marrow Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 33 Adipose Tissues Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 34 Adipose Tissues Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 35 Cord Blood Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 36 Cord Blood Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 37 Fetal Liver Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 38 Fetal Liver Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 39 Lung Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 40 Lung Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 41 Peripheral Blood Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 42 Peripheral Blood Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 43 Fallopian Tube Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 44 Fallopian Tube Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 45 Others Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 46 Bone Marrow Market Share Forecast by Region, 2022-2032 (%)
  • Figure 47 Mesenchymal Stem Cells Market by Indication Growth Prospects
  • Figure 48 Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million, AGR %)
  • Figure 49 Mesenchymal Stem Cells Market Share Forecast by Indication, 2022, 2027, 2032 (%)
  • Figure 50 Bone And Cartilage Repair Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 51 Bone And Cartilage Repair Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 52 Cardiovascular Diseases Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 53 Cardiovascular Diseases Market Share Forecast by Region, 2022-2032 (%)
  • Figure 54 Cancer Market Forecast by Region, 2022 & 2032 (US$ million)
  • Figure 55 Cancer Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 56 GvHD Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 57 GvHD Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 58 Inflammatory And Immunological Diseases Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 59 Inflammatory And Immunological Diseases Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 60 Liver Diseases Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 61 Liver Diseases Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 62 Others Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 63 Others Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 64 Mesenchymal Stem Cells Market by Application Growth Prospects
  • Figure 65 Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million, AGR %)
  • Figure 66 Mesenchymal Stem Cells Market Share Forecast by Application, 2022, 2027, 2032 (%)
  • Figure 67 Disease Modelling Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 68 Disease Modelling Repair Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 69 Drug Discovery & Development Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 70 Drug Development & Discovery Market Share Forecast by Region, 2022-2032 (%)
  • Figure 71 Stem Cell Banking Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 72 Stem Cell Banking Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 73 Tissue Engineering Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 74 Tissue Engineering Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 75 Toxicology Studies Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 76 Toxicology Studies Market Share Forecast by Region, 2022 & 2032 (%)
  • Figure 77 Others Market Forecast by Region, 2022-2032 (US$ million)
  • Figure 78 Others Market Share Forecast by Region, 2022-2032 (%)
  • Figure 79 Mesenchymal Stem Cells Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
  • Figure 80 Mesenchymal Stem Cells Market Share Forecast by Region 2022, 2027, 2032(%)
  • Figure 81 Mesenchymal Stem Cells Market by Region, 2022-2032 (US$ million, AGR (%))
  • Figure 82 North America Mesenchymal Stem Cells Market Attractiveness Index
  • Figure 83 North America Mesenchymal Stem Cells Market by Region, 2022, 2027 & 2032 (US$ million)
  • Figure 84 North America Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million)
  • Figure 85 North America Mesenchymal Stem Cells Market Share Forecast by Country, 2022 & 2032 (%)
  • Figure 86 North America Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million)
  • Figure 87 North America Mesenchymal Stem Cells Market Share Forecast by Type, 2022 & 2032 (%)
  • Figure 88 North America Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 89 North America Mesenchymal Stem Cells Market Share Forecast by Product, 2022 & 2032 (%)
  • Figure 90 North America Mesenchymal Stem Cells Market Forecast by Technology, 2022-2032 (US$ million)
  • Figure 91 North America Mesenchymal Stem Cells Market Share Forecast by Source, 2022 & 2032 (%)
  • Figure 92 North America Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million)
  • Figure 93 North America Mesenchymal Stem Cells Market Share Forecast by Indication, 2022 & 2032 (%)
  • Figure 94 North America Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million)
  • Figure 95 North America Mesenchymal Stem Cells Market Share Forecast by Application, 2022 & 2032 (%)
  • Figure 96 U.S. Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 97 Canada Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 98 Europe Mesenchymal Stem Cells Market Attractiveness Index
  • Figure 99 Europe Mesenchymal Stem Cells Market by Region, 2022, 2027 & 2032 (US$ million)
  • Figure 100 Europe Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million)
  • Figure 101 Europe Mesenchymal Stem Cells Market Share Forecast by Country, 2022 & 2032 (%)
  • Figure 102 Europe Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million)
  • Figure 103 Europe Mesenchymal Stem Cells Market Share Forecast by Type, 2022 & 2032 (%)
  • Figure 104 Europe Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 105 Europe Mesenchymal Stem Cells Market Share Forecast by Product, 2022 & 2032 (%)
  • Figure 106 Europe Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million)
  • Figure 107 Europe Mesenchymal Stem Cells Market Share Forecast by Source, 2022 & 2032 (%)
  • Figure 108 Europe Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million)
  • Figure 109 Europe Mesenchymal Stem Cells Market Share Forecast by Indication, 2022 & 2032 (%)
  • Figure 110 Europe Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million)
  • Figure 111 Europe Mesenchymal Stem Cells Market Share Forecast by Application, 2022 & 2032 (%)
  • Figure 112 Germany Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 113 France Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 114 U.K. Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 115 Italy Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 116 Spain Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 117 Rest of Europe Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 118 Asia Pacific Mesenchymal Stem Cells Market Attractiveness Index
  • Figure 119 Asia Pacific Mesenchymal Stem Cells Market by Region, 2022, 2027 & 2032 (US$ million)
  • Figure 120 Asia Pacific Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million)
  • Figure 121 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Country, 2022 & 2032 (%)
  • Figure 122 Asia Pacific Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million)
  • Figure 123 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Type, 2022 & 2032 (%)
  • Figure 124 Asia Pacific Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 125 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Product, 2022 & 2032 (%)
  • Figure 126 Asia Pacific Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million)
  • Figure 127 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Source, 2022 & 2032 (%)
  • Figure 128 Asia Pacific Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million)
  • Figure 129 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Indication, 2022 & 2032 (%)
  • Figure 130 Asia Pacific Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million)
  • Figure 131 Asia Pacific Mesenchymal Stem Cells Market Share Forecast by Application, 2022 & 2032 (%)
  • Figure 132 China Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 133 Japan Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 134 India Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 135 Australia Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 136 Rest of Asia Pacific Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 137 Latin America Mesenchymal Stem Cells Market Attractiveness Index
  • Figure 138 Latin America Mesenchymal Stem Cells Market by Region, 2022, 2027 & 2032 (US$ million)
  • Figure 139 Latin America Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million)
  • Figure 140 Latin America Mesenchymal Stem Cells Market Share Forecast by Country, 2022 & 2032 (%)
  • Figure 141 Asia Pacific Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million)
  • Figure 142 Latin America Mesenchymal Stem Cells Market Share Forecast by Type, 2022 & 2032 (%)
  • Figure 143 Latin America Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 144 Latin America Mesenchymal Stem Cells Market Share Forecast by Product, 2022 & 2032 (%)
  • Figure 145 Latin America Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million)
  • Figure 146 Latin America Mesenchymal Stem Cells Market Share Forecast by Source, 2022 & 2032 (%)
  • Figure 147 Latin America Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million)
  • Figure 148 Latin America Mesenchymal Stem Cells Market Share Forecast by Indication, 2022 & 2032 (%)
  • Figure 149 Latin America Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million)
  • Figure 150 Latin America Mesenchymal Stem Cells Market Share Forecast by Application, 2022 & 2032 (%)
  • Figure 151 Brazil Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 152 Mexico Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 153 Argentina Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 154 Rest of Latin America Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 155 Middle East & Africa Mesenchymal Stem Cells Market Attractiveness Index
  • Figure 156 Middle East & Africa Mesenchymal Stem Cells Market by Region, 2022, 2027 & 2032 (US$ million)
  • Figure 157 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Country, 2022-2032 (US$ million)
  • Figure 158 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Country, 2022 & 2032 (%)
  • Figure 159 Asia Pacific Mesenchymal Stem Cells Market Forecast by Type, 2022-2032 (US$ million)
  • Figure 160 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Type, 2022 & 2032 (%)
  • Figure 161 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Product, 2022-2032 (US$ million)
  • Figure 162 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Product, 2022 & 2032 (%)
  • Figure 163 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Source, 2022-2032 (US$ million)
  • Figure 164 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Source, 2022 & 2032 (%)
  • Figure 165 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Indication, 2022-2032 (US$ million)
  • Figure 166 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Indication, 2022 & 2032 (%)
  • Figure 167 Middle East & Africa Mesenchymal Stem Cells Market Forecast by Application, 2022-2032 (US$ million)
  • Figure 168 Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Application, 2022 & 2032 (%)
  • Figure 169 Saudi Arabia Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 170 South Africa Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 171 Turkey Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 172 Rest of Middle East & Africa Mesenchymal Stem Cells Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 173 Mesenchymal Stem Cells Market: Company Share Analysis, 2021
  • Figure 174 Thermo Fisher Scientific Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
  • Figure 175 Thermo Fisher Scientific Inc.: Regional Market Shares, 2021
  • Figure 176 Thermo Fisher Scientific Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
  • Figure 177 Thermo Fisher Scientific Inc.: R&D, 2016-2021 (US$ million, AGR%)
  • Figure 178 Merck KGaA: Net Revenue, 2016-2021 (US$ million, AGR%)
  • Figure 179 Merck KGaA: Regional Market Shares, 2021
  • Figure 180 Merck KGaA: Gross Profit, 2016-2021 (US$ million, AGR%)
  • Figure 181 Merck KGaA: R&D, 2016-2021 (US$ million, AGR%)
  • Figure 182 Lonza: Net Revenue, 2016-2021 (US$ million, AGR%)
  • Figure 183 Lonza: Regional Market Shares, 2021
  • Figure 184 Lonza: Gross Profit, 2016-2021 (US$ million, AGR%)